|
DPH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.05619999974027E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.490400000139E-07 |
| Normal-vs-Stage2 |
1.503910E-02 |
| Normal-vs-Stage3 |
5.7606000003485E-07 |
| Normal-vs-Stage4 |
3.797800E-04 |
| Stage1-vs-Stage2 |
3.445600E-01 |
| Stage1-vs-Stage3 |
1.661990E-01 |
| Stage1-vs-Stage4 |
7.174200E-01 |
| Stage2-vs-Stage3 |
8.611500E-02 |
| Stage2-vs-Stage4 |
3.218800E-01 |
| Stage3-vs-Stage4 |
6.205400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07859999998183E-06 |
| Normal-vs-AfricanAmerican |
1.300460E-03 |
| Normal-vs-Asian |
6.383700E-04 |
| Caucasian-vs-AfricanAmerican |
9.599800E-01 |
| Caucasian-vs-Asian |
6.800400E-01 |
| AfricanAmerican-vs-Asian |
7.222000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.74669999978228E-07 |
| Normal-vs-Female |
1.38540000005349E-06 |
| Male-vs-Female |
1.860390E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.80290000051775E-07 |
| Normal-vs-Age(41-60Yrs) |
1.64779999978215E-07 |
| Normal-vs-Age(61-80Yrs) |
1.836950E-03 |
| Normal-vs-Age(81-100Yrs) |
4.253000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.068800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.594200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.536020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.211600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.154580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.366600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.120590E-01 |
| Classical-VS-Follicular |
2.806400E-01 |
| Classical-VS-Other |
8.008200E-02 |
| Classical-VS-Normal |
3.43150000003956E-06 |
| Tall-VS-Follicular |
5.210200E-01 |
| Tall-VS-Other |
3.702800E-01 |
| Tall-VS-Normal |
4.08960000000125E-05 |
| Follicular-VS-Other |
3.121200E-01 |
| Follicular-VS-Normal |
8.20970000000587E-05 |
| Other-VS-Normal |
1.681010E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.38480000003261E-06 |
| Normal-vs-N1 |
6.20259999999373E-05 |
| N0-vs-N1 |
3.532200E-01 |
|
|
